Description
Currently, the only established therapeutic option for end-stage liver disease is orthotopic liver transplantation. However, the paucity of donor organs limits this option to only a few patients. From liver stem cells to advanced tissue bioengineering, this episode of EASL Studio discusses regenerative hepatology techniques as an alternative treatment for patients.
Faculty
- Prof. Pedro Baptista (Moderator)
- Prof. Tobias Cantz (Faculty)
- Prof. Karen Piper Hanley (Faculty)
- Prof. Frederic Lemaigre (Faculty)
Related episode:
ℹ️ Please click here to access the podcast version of this EASL Studio episode.